1 / 2

Trodelvy 200 mg injection price in India|9310090915

Trodelvy (sacituzumab govitecan-hziy) is an injection medication used to treat certain types of cancer. It is a type of chemotherapy called an antibody-drug conjugate, which means that it combines an antibody with a chemotherapy drug.

import
Télécharger la présentation

Trodelvy 200 mg injection price in India|9310090915

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Trodelvy 200 mg injection price in India Trodelvy is a medication that is given through intravenous (IV) infusion. Its generic name is sacituzumab govitecan-hziy, and it is a type of chemotherapy drug that is used to treat certain types of cancer. Trodelvy is indicated for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. It is also indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and either a programmed death receptor-1 (PD-1) or a programmed death-ligand 1 (PD-L1) inhibitor. Trodelvy is administered as an IV infusion over the course of approximately one hour. The dosage and frequency of the medication will depend on several factors, including the patient's body weight, the type and stage of cancer being treated, and the patient's overall health. As with all medications, there are potential side effects associated with Trodelvy. Some common side effects include nausea, vomiting, diarrhea, fatigue, decreased appetite, and hair loss. Patients should discuss any concerns or questions they have about Trodelvy and its potential side effects with their healthcare provider. Trodelvy: Dosage and Schedule Trodelvy (sacituzumab govitecan-hziy) is a chemotherapy medication used to treat metastatic triple- negative breast cancer (TNBC) and metastatic urothelial cancer (mUC).

  2. The recommended dose and schedule for Trodelvy is as follows: For metastatic TNBC: •Trodelvy is administered at a dose of 10 mg/kg as an intravenous infusion over 1 hour on days 1 and 8 of a 21-day treatment cycle. For metastatic urothelial cancer: •Trodelvy is administered at a dose of 10 mg/kg as an intravenous infusion over 1 hour on days 1 and 8 of a 21-day treatment cycle. Your doctor will determine the appropriate dose and schedule for your individual case, based on your medical history, current health, and other factors. It's essential to follow the recommended dosage and schedule for Trodelvy, as it can cause severe side effects if not used properly. If you have any questions or concerns about your Trodelvy dosage or schedule, talk to your doctor or pharmacist. Source - https://www.tumblr.com/namedpatientimport/710399884846661632/trodelvy-200-mg- injection-price-in-india?

More Related